Global Injectable Drug delivery Market: Industry Analysis and Forecast (2019-2026) – By Type, Applications, End user and Region.

Market Scenario

Global Injectable Drug delivery Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at a CAGR of around XX % during a forecast period. The increase in the prevalence of cancer and diabetes in recent years were the injectable drugs are used in the treatment and the current trend in developing the safety syringes, prefilled syringes, and auto-injectors are amplifying the market. Major factors obstructing the global injectable drug delivery market are the presence of alternatives to drug delivery procedures and safety concerns due to the increase in needle sticks during treatment. However, the increasing demand for generic injectable and bio similar is expected to generate new growth opportunities in the future for the injectable drug delivery market. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. According to the World Health Organization (WHO), in 2014, the prevalence of diabetes over the age of 18 years has increased to XX%. According to the National Cancer Institute, cancer is considered as one of the prominent causes of death globally. Around XX Mn cancer-related deaths were reported in 2015 around the globe. In terms of application, hormone disorders held the largest portion of the global injectable drug delivery market in 2018, owing to the growing frequency of hormonal disorders, such as diabetes. Based on the end-user, the home care segment held the largest portion of the injectable drug delivery market, because of the high use of self-injectable pens and other devices at home majorly by diabetic patients. Region-wise, North America held the largest share of the global market in 2017 and is expected to endure leading over the forecast period as well. This can be attributed to the increasing incidences of diabetes and a growing aging population. According to the American Diabetes Association, more than US$ XX Mn people in the world and about US$ XX Mn people in the U.S. suffer from diabetes. Additionally, the increasing adoption of technically advanced drug delivery systems is anticipated to further boost the growth of North America regional market. South American, Middle Eastern and African regions held the lowest shares of the injectable drug delivery market in 2018. Due to low awareness among the people about new technologies and lower affordability rates. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Injectable Drug Delivery Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Injectable Drug Delivery Market.

Scope of Global Injectable Drug delivery Market

Global Injectable Drug delivery Market, By Type

• Formulation o Conventional Drug Delivery  Suspensions  Solutions  Lyophilized Formulations  Emulsions o Novel Drug Delivery  Long Acting Injection Formulation  Microparticles  Colloidal Dispersions o Others • Devices o Self-Injection Devices  Needle-Free Injectors (NFI)  Wearable Injectors  Pen Injectors  Auto-Injectors  Others o Conventional Injection Devices  Prefilled Syringes  Fillable Syringes  Others

Global Injectable Drug delivery Market, By Applications

• Autoimmune Diseases • Oncology Disorders • Hormonal Disorders • Orphan Diseases • Others

Global Injectable Drug delivery Market, By End user

• Home Care • Hospital • Ambulatory Care • Physician Offices or Clinics • Others

Global Injectable Drug delivery Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America •

Key Players Operating in Global Injectable Drug delivery Market

• Baxter International, Inc., • Becton Dickinson and Company, • Gerresheimer AG, • Pfizer, Inc., • Schott AG, • Alkermes Plc., • Eli Lilly and Company, • Sandoz, • Terumo Corporation, • Teva Pharmaceuticals Industries Ltd. • Ypsomed, • Bespak • Unilife Corporation • Vetter Pharma-Fertigung GmbH & Co. KG

Table of Contents

Global Injectable Drug Delivery Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Injectable Drug Delivery Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Injectable Drug Delivery Market Analysis and Forecast 6.1. Global Injectable Drug Delivery Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Injectable Drug Delivery Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Injectable Drug Delivery Market Value Share Analysis, by Type 7.4. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Type 7.5. Global Injectable Drug Delivery Market Analysis, by Type 7.6. Global Injectable Drug Delivery Market Attractiveness Analysis, by Type 8. Global Injectable Drug Delivery Market Analysis and Forecast, by End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Injectable Drug Delivery Market Value Share Analysis, by End User 8.4. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End User 8.5. Global Injectable Drug Delivery Market Analysis, by End User 8.6. Global Injectable Drug Delivery Market Attractiveness Analysis, by End User 9. Global Injectable Drug Delivery Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Injectable Drug Delivery Market Value Share Analysis, by Application 9.4. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Application 9.5. Global Injectable Drug Delivery Market Analysis, by Application 9.6. Global Injectable Drug Delivery Market Attractiveness Analysis, by Application 10. Global Injectable Drug Delivery Market Analysis, by Region 10.1. Global Injectable Drug Delivery Market Value Share Analysis, by Region 10.2. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Region 10.3. Global Injectable Drug Delivery Market Attractiveness Analysis, by Region 11. North America Injectable Drug Delivery Market Analysis 11.1. Key Findings 11.2. North America Injectable Drug Delivery Market Overview 11.3. North America Injectable Drug Delivery Market Value Share Analysis, by Type 11.4. North America Injectable Drug Delivery Market Forecast, by Type 11.4.1. Formulation 11.4.1.1. Conventional Drug Delivery 11.4.1.1.1. Suspensions 11.4.1.1.2. Solutions 11.4.1.1.3. Lyophilized Formulations 11.4.1.1.4. Emulsions 11.4.1.2. Novel Drug Delivery 11.4.1.2.1. Long Acting Injection Formulation 11.4.1.2.2. Microparticles 11.4.1.2.3. Colloidal Dispersions 11.4.1.3. Others 11.4.2. Devices 11.4.2.1. Self-Injection Devices 11.4.2.1.1. Needle-Free Injectors (NFI) 11.4.2.1.2. Wearable Injectors 11.4.2.1.3. Pen Injectors 11.4.2.1.4. Auto-Injectors 11.4.2.1.5. Others 11.4.3. Conventional Injection Devices 11.4.3.1.1. Prefilled Syringes 11.4.3.1.2. Fillable Syringes 11.4.3.1.3. Others 11.5. North America Injectable Drug Delivery Market Value Share Analysis, by End User 11.6. North America Injectable Drug Delivery Market Forecast, by End User 11.6.1. Home Care 11.6.2. Hospital 11.6.3. Ambulatory Care 11.6.4. Physician Offices or Clinics 11.6.5. Others 11.7. North America Injectable Drug Delivery Market Value Share Analysis, by Application 11.8. North America Injectable Drug Delivery Market Forecast, by Application 11.8.1.1. Autoimmune Diseases 11.8.1.2. Oncology Disorders 11.8.1.3. Hormonal Disorders 11.8.1.4. Orphan Diseases 11.8.1.5. Others 11.9. North America Injectable Drug Delivery Market Value Share Analysis, by Country 11.10. North America Injectable Drug Delivery Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Injectable Drug Delivery Market Analysis, by Country 11.12. U.S. Injectable Drug Delivery Market Forecast, by Type 11.12.1. Formulation 11.12.1.1. Conventional Drug Delivery 11.12.1.1.1. Suspensions 11.12.1.1.2. Solutions 11.12.1.1.3. Lyophilized Formulations 11.12.1.1.4. Emulsions 11.12.1.2. Novel Drug Delivery 11.12.1.2.1. Long Acting Injection Formulation 11.12.1.2.2. Microparticles 11.12.1.2.3. Colloidal Dispersions 11.12.1.3. Others 11.12.2. Devices 11.12.2.1. Self-Injection Devices 11.12.2.1.1. Needle-Free Injectors (NFI) 11.12.2.1.2. Wearable Injectors 11.12.2.1.3. Pen Injectors 11.12.2.1.4. Auto-Injectors 11.12.2.1.5. Others 11.12.3. Conventional Injection Devices 11.12.3.1.1. Prefilled Syringes 11.12.3.1.2. Fillable Syringes 11.12.3.1.3. Others 11.13. U.S. Injectable Drug Delivery Market Forecast, by End User 11.13.1. Home Care 11.13.2. Hospital 11.13.3. Ambulatory Care 11.13.4. Physician Offices or Clinics 11.13.5. Others 11.14. U.S. Injectable Drug Delivery Market Forecast, by Application 11.14.1.1. Autoimmune Diseases 11.14.1.2. Oncology Disorders 11.14.1.3. Hormonal Disorders 11.14.1.4. Orphan Diseases 11.14.1.5. Others 11.15. Canada Injectable Drug Delivery Market Forecast, by Type 11.15.1. Formulation 11.15.1.1. Conventional Drug Delivery 11.15.1.1.1. Suspensions 11.15.1.1.2. Solutions 11.15.1.1.3. Lyophilized Formulations 11.15.1.1.4. Emulsions 11.15.1.2. Novel Drug Delivery 11.15.1.2.1. Long Acting Injection Formulation 11.15.1.2.2. Microparticles 11.15.1.2.3. Colloidal Dispersions 11.15.1.3. Others 11.15.2. Devices 11.15.2.1. Self-Injection Devices 11.15.2.1.1. Needle-Free Injectors (NFI) 11.15.2.1.2. Wearable Injectors 11.15.2.1.3. Pen Injectors 11.15.2.1.4. Auto-Injectors 11.15.2.1.5. Others 11.15.3. Conventional Injection Devices 11.15.3.1.1. Prefilled Syringes 11.15.3.1.2. Fillable Syringes 11.15.3.1.3. Others 11.16. Steel Canada Injectable Drug Delivery Market Forecast, by End User 11.16.1. Home Care 11.16.2. Hospital 11.16.3. Ambulatory Care 11.16.4. Physician Offices or Clinics 11.17. Others Canada Injectable Drug Delivery Market Forecast, by Application 11.17.1.1. Autoimmune Diseases 11.17.1.2. Oncology Disorders 11.17.1.3. Hormonal Disorders 11.17.1.4. Orphan Diseases 11.17.1.5. Others 11.18. North America Injectable Drug Delivery Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By End User 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Injectable Drug Delivery Market Analysis 12.1. Key Findings 12.2. Europe Injectable Drug Delivery Market Overview 12.3. Europe Injectable Drug Delivery Market Value Share Analysis, by Type 12.4. Europe Injectable Drug Delivery Market Forecast, by Type 12.4.1. Formulation 12.4.1.1. Conventional Drug Delivery 12.4.1.1.1. Suspensions 12.4.1.1.2. Solutions 12.4.1.1.3. Lyophilized Formulations 12.4.1.1.4. Emulsions 12.4.1.2. Novel Drug Delivery 12.4.1.2.1. Long Acting Injection Formulation 12.4.1.2.2. Microparticles 12.4.1.2.3. Colloidal Dispersions 12.4.1.3. Others 12.4.2. Devices 12.4.2.1. Self-Injection Devices 12.4.2.1.1. Needle-Free Injectors (NFI) 12.4.2.1.2. Wearable Injectors 12.4.2.1.3. Pen Injectors 12.4.2.1.4. Auto-Injectors 12.4.2.1.5. Others 12.4.3. Conventional Injection Devices 12.4.3.1.1. Prefilled Syringes 12.4.3.1.2. Fillable Syringes 12.4.3.1.3. Others 12.5. Europe Injectable Drug Delivery Market Value Share Analysis, by End User 12.6. Europe Injectable Drug Delivery Market Forecast, by End User 12.6.1. Home Care 12.6.2. Hospital 12.6.3. Ambulatory Care 12.6.4. Physician Offices or Clinics 12.6.5. Others 12.7. Europe Injectable Drug Delivery Market Value Share Analysis, by Application 12.8. Europe Injectable Drug Delivery Market Forecast, by Application 12.8.1.1. Autoimmune Diseases 12.8.1.2. Oncology Disorders 12.8.1.3. Hormonal Disorders 12.8.1.4. Orphan Diseases 12.8.1.5. Others 12.9. Europe Injectable Drug Delivery Market Value Share Analysis, by Country 12.10. Europe Injectable Drug Delivery Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Injectable Drug Delivery Market Analysis, by Country 12.12. Germany Injectable Drug Delivery Market Forecast, by Type 12.12.1. Formulation 12.12.1.1. Conventional Drug Delivery 12.12.1.1.1. Suspensions 12.12.1.1.2. Solutions 12.12.1.1.3. Lyophilized Formulations 12.12.1.1.4. Emulsions 12.12.1.2. Novel Drug Delivery 12.12.1.2.1. Long Acting Injection Formulation 12.12.1.2.2. Microparticles 12.12.1.2.3. Colloidal Dispersions 12.12.1.3. Others 12.12.2. Devices 12.12.2.1. Self-Injection Devices 12.12.2.1.1. Needle-Free Injectors (NFI) 12.12.2.1.2. Wearable Injectors 12.12.2.1.3. Pen Injectors 12.12.2.1.4. Auto-Injectors 12.12.2.1.5. Others 12.12.3. Conventional Injection Devices 12.12.3.1.1. Prefilled Syringes 12.12.3.1.2. Fillable Syringes 12.12.3.1.3. Others 12.13. Germany Injectable Drug Delivery Market Forecast, by End User 12.13.1. Home Care 12.13.2. Hospital 12.13.3. Ambulatory Care 12.13.4. Physician Offices or Clinics 12.13.5. Others 12.14. Germany Injectable Drug Delivery Market Forecast, by Application 12.14.1.1. Autoimmune Diseases 12.14.1.2. Oncology Disorders 12.14.1.3. Hormonal Disorders 12.14.1.4. Orphan Diseases 12.14.1.5. Others 12.15. U.K. Injectable Drug Delivery Market Forecast, by Type 12.15.1. Formulation 12.15.1.1. Conventional Drug Delivery 12.15.1.1.1. Suspensions 12.15.1.1.2. Solutions 12.15.1.1.3. Lyophilized Formulations 12.15.1.1.4. Emulsions 12.15.1.2. Novel Drug Delivery 12.15.1.2.1. Long Acting Injection Formulation 12.15.1.2.2. Microparticles 12.15.1.2.3. Colloidal Dispersions 12.15.1.3. Others 12.15.2. Devices 12.15.2.1. Self-Injection Devices 12.15.2.1.1. Needle-Free Injectors (NFI) 12.15.2.1.2. Wearable Injectors 12.15.2.1.3. Pen Injectors 12.15.2.1.4. Auto-Injectors 12.15.2.1.5. Others 12.15.3. Conventional Injection Devices 12.15.3.1.1. Prefilled Syringes 12.15.3.1.2. Fillable Syringes 12.15.3.1.3. Others 12.16. U.K. Injectable Drug Delivery Market Forecast, by End User 12.16.1. Home Care 12.16.2. Hospital 12.16.3. Ambulatory Care 12.16.4. Physician Offices or Clinics 12.16.5. Others 12.17. U.K. Injectable Drug Delivery Market Forecast, by Application 12.17.1.1. Autoimmune Diseases 12.17.1.2. Oncology Disorders 12.17.1.3. Hormonal Disorders 12.17.1.4. Orphan Diseases 12.17.1.5. Others 12.18. France Injectable Drug Delivery Market Forecast, by Type 12.18.1. Formulation 12.18.1.1. Conventional Drug Delivery 12.18.1.1.1. Suspensions 12.18.1.1.2. Solutions 12.18.1.1.3. Lyophilized Formulations 12.18.1.1.4. Emulsions 12.18.1.2. Novel Drug Delivery 12.18.1.2.1. Long Acting Injection Formulation 12.18.1.2.2. Microparticles 12.18.1.2.3. Colloidal Dispersions 12.18.1.3. Others 12.18.2. Devices 12.18.2.1. Self-Injection Devices 12.18.2.1.1. Needle-Free Injectors (NFI) 12.18.2.1.2. Wearable Injectors 12.18.2.1.3. Pen Injectors 12.18.2.1.4. Auto-Injectors 12.18.2.1.5. Others 12.18.3. Conventional Injection Devices 12.18.3.1.1. Prefilled Syringes 12.18.3.1.2. Fillable Syringes 12.18.3.1.3. Others 12.19. France Injectable Drug Delivery Market Forecast, by End User 12.19.1. Home Care 12.19.2. Hospital 12.19.3. Ambulatory Care 12.19.4. Physician Offices or Clinics 12.19.5. Others 12.20. France Injectable Drug Delivery Market Forecast, by Application 12.20.1.1. Autoimmune Diseases 12.20.1.2. Oncology Disorders 12.20.1.3. Hormonal Disorders 12.20.1.4. Orphan Diseases 12.20.1.5. Others 12.21. Italy Injectable Drug Delivery Market Forecast, by Type 12.21.1. Formulation 12.21.1.1. Conventional Drug Delivery 12.21.1.1.1. Suspensions 12.21.1.1.2. Solutions 12.21.1.1.3. Lyophilized Formulations 12.21.1.1.4. Emulsions 12.21.1.2. Novel Drug Delivery 12.21.1.2.1. Long Acting Injection Formulation 12.21.1.2.2. Microparticles 12.21.1.2.3. Colloidal Dispersions 12.21.1.3. Others 12.21.2. Devices 12.21.2.1. Self-Injection Devices 12.21.2.1.1. Needle-Free Injectors (NFI) 12.21.2.1.2. Wearable Injectors 12.21.2.1.3. Pen Injectors 12.21.2.1.4. Auto-Injectors 12.21.2.1.5. Others 12.21.3. Conventional Injection Devices 12.21.3.1.1. Prefilled Syringes 12.21.3.1.2. Fillable Syringes 12.21.3.1.3. Others 12.22. Italy Injectable Drug Delivery Market Forecast, by End User 12.22.1. Home Care 12.22.2. Hospital 12.22.3. Ambulatory Care 12.22.4. Physician Offices or Clinics 12.22.5. Others 12.23. Italy Injectable Drug Delivery Market Forecast, by Application 12.23.1.1. Autoimmune Diseases 12.23.1.2. Oncology Disorders 12.23.1.3. Hormonal Disorders 12.23.1.4. Orphan Diseases 12.23.1.5. Others 12.24. Spain Injectable Drug Delivery Market Forecast, by Type 12.24.1. Formulation 12.24.1.1. Conventional Drug Delivery 12.24.1.1.1. Suspensions 12.24.1.1.2. Solutions 12.24.1.1.3. Lyophilized Formulations 12.24.1.1.4. Emulsions 12.24.1.2. Novel Drug Delivery 12.24.1.2.1. Long Acting Injection Formulation 12.24.1.2.2. Microparticles 12.24.1.2.3. Colloidal Dispersions 12.24.1.3. Others 12.24.2. Devices 12.24.2.1. Self-Injection Devices 12.24.2.1.1. Needle-Free Injectors (NFI) 12.24.2.1.2. Wearable Injectors 12.24.2.1.3. Pen Injectors 12.24.2.1.4. Auto-Injectors 12.24.2.1.5. Others 12.24.3. Conventional Injection Devices 12.24.3.1.1. Prefilled Syringes 12.24.3.1.2. Fillable Syringes 12.24.3.1.3. Others 12.25. Spain Injectable Drug Delivery Market Forecast, by End User 12.25.1. Home Care 12.25.2. Hospital 12.25.3. Ambulatory Care 12.25.4. Physician Offices or Clinics 12.25.5. Others 12.26. Spain Injectable Drug Delivery Market Forecast, by Application 12.26.1.1. Autoimmune Diseases 12.26.1.2. Oncology Disorders 12.26.1.3. Hormonal Disorders 12.26.1.4. Orphan Diseases 12.26.1.5. Others 12.27. Rest of Europe Injectable Drug Delivery Market Forecast, by Type 12.27.1. Formulation 12.27.1.1. Conventional Drug Delivery 12.27.1.1.1. Suspensions 12.27.1.1.2. Solutions 12.27.1.1.3. Lyophilized Formulations 12.27.1.1.4. Emulsions 12.27.1.2. Novel Drug Delivery 12.27.1.2.1. Long Acting Injection Formulation 12.27.1.2.2. Microparticles 12.27.1.2.3. Colloidal Dispersions 12.27.1.3. Others 12.27.2. Devices 12.27.2.1. Self-Injection Devices 12.27.2.1.1. Needle-Free Injectors (NFI) 12.27.2.1.2. Wearable Injectors 12.27.2.1.3. Pen Injectors 12.27.2.1.4. Auto-Injectors 12.27.2.1.5. Others 12.27.3. Conventional Injection Devices 12.27.3.1.1. Prefilled Syringes 12.27.3.1.2. Fillable Syringes 12.27.3.1.3. Others 12.28. Rest of Europe Injectable Drug Delivery Market Forecast, by End User 12.28.1. Home Care 12.28.2. Hospital 12.28.3. Ambulatory Care 12.28.4. Physician Offices or Clinics 12.28.5. Others 12.29. Rest Of Europe Injectable Drug Delivery Market Forecast, by Application 12.29.1.1. Autoimmune Diseases 12.29.1.2. Oncology Disorders 12.29.1.3. Hormonal Disorders 12.29.1.4. Orphan Diseases 12.29.1.5. Others 12.30. Europe Injectable Drug Delivery Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By End User 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Injectable Drug Delivery Market Analysis 13.1. Key Findings 13.2. Asia Pacific Injectable Drug Delivery Market Overview 13.3. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by Type 13.4. Asia Pacific Injectable Drug Delivery Market Forecast, by Type 13.4.1. Formulation 13.4.1.1. Conventional Drug Delivery 13.4.1.1.1. Suspensions 13.4.1.1.2. Solutions 13.4.1.1.3. Lyophilized Formulations 13.4.1.1.4. Emulsions 13.4.1.2. Novel Drug Delivery 13.4.1.2.1. Long Acting Injection Formulation 13.4.1.2.2. Microparticles 13.4.1.2.3. Colloidal Dispersions 13.4.1.3. Others 13.4.2. Devices 13.4.2.1. Self-Injection Devices 13.4.2.1.1. Needle-Free Injectors (NFI) 13.4.2.1.2. Wearable Injectors 13.4.2.1.3. Pen Injectors 13.4.2.1.4. Auto-Injectors 13.4.2.1.5. Others 13.4.3. Conventional Injection Devices 13.4.3.1.1. Prefilled Syringes 13.4.3.1.2. Fillable Syringes 13.4.3.1.3. Others 13.5. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by End User 13.6. Asia Pacific Injectable Drug Delivery Market Forecast, by End User 13.6.1. Home Care 13.6.2. Hospital 13.6.3. Ambulatory Care 13.6.4. Physician Offices or Clinics 13.6.5. Others 13.7. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by Application 13.8. Asia Pacific Injectable Drug Delivery Market Forecast, by Application 13.8.1.1. Autoimmune Diseases 13.8.1.2. Oncology Disorders 13.8.1.3. Hormonal Disorders 13.8.1.4. Orphan Diseases 13.8.1.5. Others 13.9. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by Country 13.10. Asia Pacific Injectable Drug Delivery Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Injectable Drug Delivery Market Analysis, by Country 13.12. China Injectable Drug Delivery Market Forecast, by Type 13.12.1. Formulation 13.12.1.1. Conventional Drug Delivery 13.12.1.1.1. Suspensions 13.12.1.1.2. Solutions 13.12.1.1.3. Lyophilized Formulations 13.12.1.1.4. Emulsions 13.12.1.2. Novel Drug Delivery 13.12.1.2.1. Long Acting Injection Formulation 13.12.1.2.2. Microparticles 13.12.1.2.3. Colloidal Dispersions 13.12.1.3. Others 13.12.2. Devices 13.12.2.1. Self-Injection Devices 13.12.2.1.1. Needle-Free Injectors (NFI) 13.12.2.1.2. Wearable Injectors 13.12.2.1.3. Pen Injectors 13.12.2.1.4. Auto-Injectors 13.12.2.1.5. Others 13.12.3. Conventional Injection Devices 13.12.3.1.1. Prefilled Syringes 13.12.3.1.2. Fillable Syringes 13.12.3.1.3. Others 13.13. China Injectable Drug Delivery Market Forecast, by End User 13.13.1. Home Care 13.13.2. Hospital 13.13.3. Ambulatory Care 13.13.4. Physician Offices or Clinics 13.13.5. Others 13.14. China Injectable Drug Delivery Market Forecast, by Application 13.14.1.1. Autoimmune Diseases 13.14.1.2. Oncology Disorders 13.14.1.3. Hormonal Disorders 13.14.1.4. Orphan Diseases 13.14.1.5. Others 13.15. India Injectable Drug Delivery Market Forecast, by Type 13.15.1. Formulation 13.15.1.1. Conventional Drug Delivery 13.15.1.1.1. Suspensions 13.15.1.1.2. Solutions 13.15.1.1.3. Lyophilized Formulations 13.15.1.1.4. Emulsions 13.15.1.2. Novel Drug Delivery 13.15.1.2.1. Long Acting Injection Formulation 13.15.1.2.2. Microparticles 13.15.1.2.3. Colloidal Dispersions 13.15.1.3. Others 13.15.2. Devices 13.15.2.1. Self-Injection Devices 13.15.2.1.1. Needle-Free Injectors (NFI) 13.15.2.1.2. Wearable Injectors 13.15.2.1.3. Pen Injectors 13.15.2.1.4. Auto-Injectors 13.15.2.1.5. Others 13.15.3. Conventional Injection Devices 13.15.3.1.1. Prefilled Syringes 13.15.3.1.2. Fillable Syringes 13.15.3.1.3. Others 13.16. India Injectable Drug Delivery Market Forecast, by End User 13.16.1. Home Care 13.16.2. Hospital 13.16.3. Ambulatory Care 13.16.4. Physician Offices or Clinics 13.16.5. Others 13.17. India Injectable Drug Delivery Market Forecast, by Application 13.17.1.1. Autoimmune Diseases 13.17.1.2. Oncology Disorders 13.17.1.3. Hormonal Disorders 13.17.1.4. Orphan Diseases 13.17.1.5. Others 13.18. Japan Injectable Drug Delivery Market Forecast, by Type 13.18.1. Formulation 13.18.1.1. Conventional Drug Delivery 13.18.1.1.1. Suspensions 13.18.1.1.2. Solutions 13.18.1.1.3. Lyophilized Formulations 13.18.1.1.4. Emulsions 13.18.1.2. Novel Drug Delivery 13.18.1.2.1. Long Acting Injection Formulation 13.18.1.2.2. Microparticles 13.18.1.2.3. Colloidal Dispersions 13.18.1.3. Others 13.18.2. Devices 13.18.2.1. Self-Injection Devices 13.18.2.1.1. Needle-Free Injectors (NFI) 13.18.2.1.2. Wearable Injectors 13.18.2.1.3. Pen Injectors 13.18.2.1.4. Auto-Injectors 13.18.2.1.5. Others 13.18.3. Conventional Injection Devices 13.18.3.1.1. Prefilled Syringes 13.18.3.1.2. Fillable Syringes 13.18.3.1.3. Others 13.19. Japan Injectable Drug Delivery Market Forecast, by End User 13.19.1. Home Care 13.19.2. Hospital 13.19.3. Ambulatory Care 13.19.4. Physician Offices or Clinics 13.19.5. Others 13.20. Japan Injectable Drug Delivery Market Forecast, by Application 13.20.1.1. Autoimmune Diseases 13.20.1.2. Oncology Disorders 13.20.1.3. Hormonal Disorders 13.20.1.4. Orphan Diseases 13.20.1.5. Others 13.21. ASEAN Injectable Drug Delivery Market Forecast, by Type 13.21.1. Formulation 13.21.1.1. Conventional Drug Delivery 13.21.1.1.1. Suspensions 13.21.1.1.2. Solutions 13.21.1.1.3. Lyophilized Formulations 13.21.1.1.4. Emulsions 13.21.1.2. Novel Drug Delivery 13.21.1.2.1. Long Acting Injection Formulation 13.21.1.2.2. Microparticles 13.21.1.2.3. Colloidal Dispersions 13.21.1.3. Others 13.21.2. Devices 13.21.2.1. Self-Injection Devices 13.21.2.1.1. Needle-Free Injectors (NFI) 13.21.2.1.2. Wearable Injectors 13.21.2.1.3. Pen Injectors 13.21.2.1.4. Auto-Injectors 13.21.2.1.5. Others 13.21.3. Conventional Injection Devices 13.21.3.1.1. Prefilled Syringes 13.21.3.1.2. Fillable Syringes 13.21.3.1.3. Others 13.22. ASEAN Injectable Drug Delivery Market Forecast, by End User 13.22.1. Home Care 13.22.2. Hospital 13.22.3. Ambulatory Care 13.22.4. Physician Offices or Clinics 13.22.5. Others 13.23. ASEAN Injectable Drug Delivery Market Forecast, by Application 13.23.1.1. Autoimmune Diseases 13.23.1.2. Oncology Disorders 13.23.1.3. Hormonal Disorders 13.23.1.4. Orphan Diseases 13.23.1.5. Others 13.24. Rest of Asia Pacific Injectable Drug Delivery Market Forecast, by Type 13.24.1. Formulation 13.24.1.1. Conventional Drug Delivery 13.24.1.1.1. Suspensions 13.24.1.1.2. Solutions 13.24.1.1.3. Lyophilized Formulations 13.24.1.1.4. Emulsions 13.24.1.2. Novel Drug Delivery 13.24.1.2.1. Long Acting Injection Formulation 13.24.1.2.2. Microparticles 13.24.1.2.3. Colloidal Dispersions 13.24.1.3. Others 13.24.2. Devices 13.24.2.1. Self-Injection Devices 13.24.2.1.1. Needle-Free Injectors (NFI) 13.24.2.1.2. Wearable Injectors 13.24.2.1.3. Pen Injectors 13.24.2.1.4. Auto-Injectors 13.24.2.1.5. Others 13.24.3. Conventional Injection Devices 13.24.3.1.1. Prefilled Syringes 13.24.3.1.2. Fillable Syringes 13.24.3.1.3. Others 13.25. Rest of Asia Pacific Injectable Drug Delivery Market Forecast, by End User 13.25.1. Home Care 13.25.2. Hospital 13.25.3. Ambulatory Care 13.25.4. Physician Offices or Clinics 13.25.5. Others 13.26. Rest of Asia Pacific Injectable Drug Delivery Market Forecast, by Application 13.26.1.1. Autoimmune Diseases 13.26.1.2. Oncology Disorders 13.26.1.3. Hormonal Disorders 13.26.1.4. Orphan Diseases 13.26.1.5. Others 13.27. Asia Pacific Injectable Drug Delivery Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By End User 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Injectable Drug Delivery Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Injectable Drug Delivery Market Overview 14.3. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by Type 14.4. Middle East & Africa Injectable Drug Delivery Market Forecast, by Type 14.4.1. Formulation 14.4.1.1. Conventional Drug Delivery 14.4.1.1.1. Suspensions 14.4.1.1.2. Solutions 14.4.1.1.3. Lyophilized Formulations 14.4.1.1.4. Emulsions 14.4.1.2. Novel Drug Delivery 14.4.1.2.1. Long Acting Injection Formulation 14.4.1.2.2. Microparticles 14.4.1.2.3. Colloidal Dispersions 14.4.1.3. Others 14.4.2. Devices 14.4.2.1. Self-Injection Devices 14.4.2.1.1. Needle-Free Injectors (NFI) 14.4.2.1.2. Wearable Injectors 14.4.2.1.3. Pen Injectors 14.4.2.1.4. Auto-Injectors 14.4.2.1.5. Others 14.4.3. Conventional Injection Devices 14.4.3.1.1. Prefilled Syringes 14.4.3.1.2. Fillable Syringes 14.4.3.1.3. Others 14.5. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by End User 14.6. Middle East & Africa Injectable Drug Delivery Market Forecast, by End User 14.6.1. Home Care 14.6.2. Hospital 14.6.3. Ambulatory Care 14.6.4. Physician Offices or Clinics 14.6.5. Others 14.7. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by Application 14.8. Middle East & Africa Injectable Drug Delivery Market Forecast, by Application 14.8.1.1. Autoimmune Diseases 14.8.1.2. Oncology Disorders 14.8.1.3. Hormonal Disorders 14.8.1.4. Orphan Diseases 14.8.1.5. Others 14.9. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by Country 14.10. Middle East & Africa Injectable Drug Delivery Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Injectable Drug Delivery Market Analysis, by Country 14.12. GCC Injectable Drug Delivery Market Forecast, by Type 14.12.1. Formulation 14.12.1.1. Conventional Drug Delivery 14.12.1.1.1. Suspensions 14.12.1.1.2. Solutions 14.12.1.1.3. Lyophilized Formulations 14.12.1.1.4. Emulsions 14.12.1.2. Novel Drug Delivery 14.12.1.2.1. Long Acting Injection Formulation 14.12.1.2.2. Microparticles 14.12.1.2.3. Colloidal Dispersions 14.12.1.3. Others 14.12.2. Devices 14.12.2.1. Self-Injection Devices 14.12.2.1.1. Needle-Free Injectors (NFI) 14.12.2.1.2. Wearable Injectors 14.12.2.1.3. Pen Injectors 14.12.2.1.4. Auto-Injectors 14.12.2.1.5. Others 14.12.3. Conventional Injection Devices 14.12.3.1.1. Prefilled Syringes 14.12.3.1.2. Fillable Syringes 14.12.3.1.3. Others 14.13. GCC Injectable Drug Delivery Market Forecast, by End User 14.13.1. Home Care 14.13.2. Hospital 14.13.3. Ambulatory Care 14.13.4. Physician Offices or Clinics 14.13.5. Others 14.14. GCC Injectable Drug Delivery Market Forecast, by Application 14.14.1.1. Autoimmune Diseases 14.14.1.2. Oncology Disorders 14.14.1.3. Hormonal Disorders 14.14.1.4. Orphan Diseases 14.14.1.5. Others 14.15. South Africa Injectable Drug Delivery Market Forecast, by Type 14.15.1. Formulation 14.15.1.1. Conventional Drug Delivery 14.15.1.1.1. Suspensions 14.15.1.1.2. Solutions 14.15.1.1.3. Lyophilized Formulations 14.15.1.1.4. Emulsions 14.15.1.2. Novel Drug Delivery 14.15.1.2.1. Long Acting Injection Formulation 14.15.1.2.2. Microparticles 14.15.1.2.3. Colloidal Dispersions 14.15.1.3. Others 14.15.2. Devices 14.15.2.1. Self-Injection Devices 14.15.2.1.1. Needle-Free Injectors (NFI) 14.15.2.1.2. Wearable Injectors 14.15.2.1.3. Pen Injectors 14.15.2.1.4. Auto-Injectors 14.15.2.1.5. Others 14.15.3. Conventional Injection Devices 14.15.3.1.1. Prefilled Syringes 14.15.3.1.2. Fillable Syringes 14.15.3.1.3. Others 14.16. South Africa Injectable Drug Delivery Market Forecast, by End User 14.16.1. Home Care 14.16.2. Hospital 14.16.3. Ambulatory Care 14.16.4. Physician Offices or Clinics 14.16.5. Others 14.17. South Africa Injectable Drug Delivery Market Forecast, by Application 14.17.1.1. Autoimmune Diseases 14.17.1.2. Oncology Disorders 14.17.1.3. Hormonal Disorders 14.17.1.4. Orphan Diseases 14.17.1.5. Others 14.18. Rest of Middle East & Africa Injectable Drug Delivery Market Forecast, by Type 14.18.1. Formulation 14.18.1.1. Conventional Drug Delivery 14.18.1.1.1. Suspensions 14.18.1.1.2. Solutions 14.18.1.1.3. Lyophilized Formulations 14.18.1.1.4. Emulsions 14.18.1.2. Novel Drug Delivery 14.18.1.2.1. Long Acting Injection Formulation 14.18.1.2.2. Microparticles 14.18.1.2.3. Colloidal Dispersions 14.18.1.3. Others 14.18.2. Devices 14.18.2.1. Self-Injection Devices 14.18.2.1.1. Needle-Free Injectors (NFI) 14.18.2.1.2. Wearable Injectors 14.18.2.1.3. Pen Injectors 14.18.2.1.4. Auto-Injectors 14.18.2.1.5. Others 14.18.3. Conventional Injection Devices 14.18.3.1.1. Prefilled Syringes 14.18.3.1.2. Fillable Syringes 14.18.3.1.3. Others 14.19. Rest of Middle East & Africa Injectable Drug Delivery Market Forecast, by End User 14.19.1. Home Care 14.19.2. Hospital 14.19.3. Ambulatory Care 14.19.4. Physician Offices or Clinics 14.19.5. Others 14.20. Rest of Middle East & Africa Injectable Drug Delivery Market Forecast, by Application 14.20.1.1. Autoimmune Diseases 14.20.1.2. Oncology Disorders 14.20.1.3. Hormonal Disorders 14.20.1.4. Orphan Diseases 14.20.1.5. Others 14.21. Middle East & Africa Injectable Drug Delivery Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By End User 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Injectable Drug Delivery Market Analysis 15.1. Key Findings 15.2. South America Injectable Drug Delivery Market Overview 15.3. South America Injectable Drug Delivery Market Value Share Analysis, by Type 15.4. South America Injectable Drug Delivery Market Forecast, by Type 15.4.1. Formulation 15.4.1.1. Conventional Drug Delivery 15.4.1.1.1. Suspensions 15.4.1.1.2. Solutions 15.4.1.1.3. Lyophilized Formulations 15.4.1.1.4. Emulsions 15.4.1.2. Novel Drug Delivery 15.4.1.2.1. Long Acting Injection Formulation 15.4.1.2.2. Microparticles 15.4.1.2.3. Colloidal Dispersions 15.4.1.3. Others 15.4.2. Devices 15.4.2.1. Self-Injection Devices 15.4.2.1.1. Needle-Free Injectors (NFI) 15.4.2.1.2. Wearable Injectors 15.4.2.1.3. Pen Injectors 15.4.2.1.4. Auto-Injectors 15.4.2.1.5. Others 15.4.3. Conventional Injection Devices 15.4.3.1.1. Prefilled Syringes 15.4.3.1.2. Fillable Syringes 15.4.3.1.3. Others 15.5. South America Injectable Drug Delivery Market Value Share Analysis, by End User 15.6. South America Injectable Drug Delivery Market Forecast, by End User 15.6.1. Home Care 15.6.2. Hospital 15.6.3. Ambulatory Care 15.6.4. Physician Offices or Clinics 15.6.5. Others 15.7. South America Injectable Drug Delivery Market Value Share Analysis, by Application 15.8. South America Injectable Drug Delivery Market Forecast, by Application 15.8.1.1. Autoimmune Diseases 15.8.1.2. Oncology Disorders 15.8.1.3. Hormonal Disorders 15.8.1.4. Orphan Diseases 15.8.1.5. Others 15.9. South America Injectable Drug Delivery Market Value Share Analysis, by Country 15.10. South America Injectable Drug Delivery Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Injectable Drug Delivery Market Analysis, by Country 15.12. Brazil Injectable Drug Delivery Market Forecast, by Type 15.12.1. Formulation 15.12.1.1. Conventional Drug Delivery 15.12.1.1.1. Suspensions 15.12.1.1.2. Solutions 15.12.1.1.3. Lyophilized Formulations 15.12.1.1.4. Emulsions 15.12.1.2. Novel Drug Delivery 15.12.1.2.1. Long Acting Injection Formulation 15.12.1.2.2. Microparticles 15.12.1.2.3. Colloidal Dispersions 15.12.1.3. Others 15.12.2. Devices 15.12.2.1. Self-Injection Devices 15.12.2.1.1. Needle-Free Injectors (NFI) 15.12.2.1.2. Wearable Injectors 15.12.2.1.3. Pen Injectors 15.12.2.1.4. Auto-Injectors 15.12.2.1.5. Others 15.12.3. Conventional Injection Devices 15.12.3.1.1. Prefilled Syringes 15.12.3.1.2. Fillable Syringes 15.12.3.1.3. Others 15.13. Brazil Injectable Drug Delivery Market Forecast, by End User 15.13.1. Home Care 15.13.2. Hospital 15.13.3. Ambulatory Care 15.13.4. Physician Offices or Clinics 15.13.5. Others 15.14. Brazil Injectable Drug Delivery Market Forecast, by Application 15.14.1.1. Autoimmune Diseases 15.14.1.2. Oncology Disorders 15.14.1.3. Hormonal Disorders 15.14.1.4. Orphan Diseases 15.14.1.5. Others 15.15. Mexico Injectable Drug Delivery Market Forecast, by Type 15.15.1. Formulation 15.15.1.1. Conventional Drug Delivery 15.15.1.1.1. Suspensions 15.15.1.1.2. Solutions 15.15.1.1.3. Lyophilized Formulations 15.15.1.1.4. Emulsions 15.15.1.2. Novel Drug Delivery 15.15.1.2.1. Long Acting Injection Formulation 15.15.1.2.2. Microparticles 15.15.1.2.3. Colloidal Dispersions 15.15.1.3. Others 15.15.2. Devices 15.15.2.1. Self-Injection Devices 15.15.2.1.1. Needle-Free Injectors (NFI) 15.15.2.1.2. Wearable Injectors 15.15.2.1.3. Pen Injectors 15.15.2.1.4. Auto-Injectors 15.15.2.1.5. Others 15.15.3. Conventional Injection Devices 15.15.3.1.1. Prefilled Syringes 15.15.3.1.2. Fillable Syringes 15.15.3.1.3. Others 15.16. Mexico Injectable Drug Delivery Market Forecast, by End User 15.16.1. Home Care 15.16.2. Hospital 15.16.3. Ambulatory Care 15.16.4. Physician Offices or Clinics 15.16.5. Others 15.17. Mexico Injectable Drug Delivery Market Forecast, by Application 15.17.1.1. Autoimmune Diseases 15.17.1.2. Oncology Disorders 15.17.1.3. Hormonal Disorders 15.17.1.4. Orphan Diseases 15.17.1.5. Others 15.18. Rest of South America Injectable Drug Delivery Market Forecast, by Type 15.18.1. Formulation 15.18.1.1. Conventional Drug Delivery 15.18.1.1.1. Suspensions 15.18.1.1.2. Solutions 15.18.1.1.3. Lyophilized Formulations 15.18.1.1.4. Emulsions 15.18.1.2. Novel Drug Delivery 15.18.1.2.1. Long Acting Injection Formulation 15.18.1.2.2. Microparticles 15.18.1.2.3. Colloidal Dispersions 15.18.1.3. Others 15.18.2. Devices 15.18.2.1. Self-Injection Devices 15.18.2.1.1. Needle-Free Injectors (NFI) 15.18.2.1.2. Wearable Injectors 15.18.2.1.3. Pen Injectors 15.18.2.1.4. Auto-Injectors 15.18.2.1.5. Others 15.18.3. Conventional Injection Devices 15.18.3.1.1. Prefilled Syringes 15.18.3.1.2. Fillable Syringes 15.18.3.1.3. Others 15.19. Rest of South America Injectable Drug Delivery Market Forecast, by End User 15.19.1. Home Care 15.19.2. Hospital 15.19.3. Ambulatory Care 15.19.4. Physician Offices or Clinics 15.19.5. Others 15.20. Rest of South America Injectable Drug Delivery Market Forecast, by Application 15.20.1.1. Autoimmune Diseases 15.20.1.2. Oncology Disorders 15.20.1.3. Hormonal Disorders 15.20.1.4. Orphan Diseases 15.20.1.5. Others 15.21. South America Injectable Drug Delivery Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By End User 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Baxter International, Inc., 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Becton Dickinson and Company, 16.3.3. Gerresheimer AG, 16.3.4. Pfizer, Inc., 16.3.5. Schott AG, 16.3.6. Alkermes Plc., 16.3.7. Eli Lilly and Company, 16.3.8. Sandoz, 16.3.9. Terumo Corporation, 16.3.10. Teva Pharmaceuticals Industries Ltd. 16.3.11. Ypsomed, 16.3.12. Bespak 16.3.13. Unilife Corporation 16.3.14. Vetter Pharma-Fertigung GmbH & Co. KG 17. Primary Key Insights

About This Report

Report ID 33773
Category Healthcare
Published Date Aug 2019
No of Pages 186
Contact Us